Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | APC |
Variant | P1443Lfs*30 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | APC P1443Lfs*30 indicates a shift in the reading frame starting at amino acid 1443 and terminating 30 residues downstream causing a premature truncation of the 2843 amino acid Apc protein (UniProt.org). P1443Lfs*30 has not been characterized, however, due to the effects of other truncation mutations downstream of P1443 (PMID: 18199528, PMID: 10346819), is predicted to lead to a loss of Apc protein function. |
Associated Drug Resistance | |
Category Variants Paths |
APC mutant APC inact mut APC P1443fs APC P1443Lfs*30 |
Transcript | NM_000038.6 |
gDNA | chr5:g.112839922delC |
cDNA | c.4328delC |
Protein | p.P1443Lfs*30 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001407454.1 | chr5:g.(112840170_112840262) | c.(4327_4419) | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_000038.5 | chr5:g.112839922delC | c.4328delC | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001354895.2 | chr5:g.112839922delC | c.4328delC | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001354895.1 | chr5:g.112839922delC | c.4328delC | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001407456.1 | chr5:g.(112840170_112840262) | c.(4327_4419) | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001407455.1 | chr5:g.(112840170_112840262) | c.(4327_4419) | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001354897.1 | chr5:g.(112839891_112839983) | c.(4327_4419) | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001127510.3 | chr5:g.112839922delC | c.4328delC | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_000038 | chr5:g.112839920delT | c.4326delT | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001354905.1 | chr5:g.112840401_112840402insTAAA | c.4327_4328insTAAA | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001354905.2 | chr5:g.112840401_112840402insTAAA | c.4327_4328insTAAA | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001127510 | chr5:g.112839920delT | c.4326delT | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001407457.1 | chr5:g.(112840170_112840262) | c.(4327_4419) | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001127510.2 | chr5:g.112839922delC | c.4328delC | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001407452.1 | chr5:g.112839951_112839952insTCCCCCCCCCCCCCCCCCCCCCCCCAAAA | c.4327_4328insTCCCCCCCCCCCCCCCCCCCCCCCCAAAA | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001354897.2 | chr5:g.(112839891_112839983) | c.(4327_4419) | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_001407450.1 | chr5:g.112839922delC | c.4328delC | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
NM_000038.6 | chr5:g.112839922delC | c.4328delC | p.P1443Lfs*30 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|